Gadoxetate Disodium Patent Expiration

Gadoxetate Disodium is Used for imaging the liver using magnetic resonance technology. It was first introduced by Bayer Healthcare Pharmaceuticals Inc in its drug Eovist on Jul 3, 2008.


Gadoxetate Disodium Patents

Given below is the list of patents protecting Gadoxetate Disodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Eovist US6039931 Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production Nov 13, 2021

(Expired)

Bayer Hlthcare
Eovist US5798092 Derivatized DTPA complexes pharmaceutical agents containing these compounds, their use, and processes for their production Aug 25, 2015

(Expired)

Bayer Hlthcare



Gadoxetate Disodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List